The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.
Carex Health Brands has established its operations in Canada with the acquisition of a Nova Scotia-based leader in the lifting seat and light therapy markets.
